edh649
Joined 13 years ago
Joined 13 years ago
https://www.standard.co.uk/news/uk/commuters-ordered-to-repa...
Once you've seen it you'll be baffled as to why it isn't a global solution. No need for the employee or others to wait while you count your coins or bag up, and no need for anyone to wait behind you while you wait for the self-service checkout to weigh each item individually, fail to scan etc.
https://www.forbes.com/sites/forbes-personal-shopper/2021/09...
https://timharford.com/2021/03/cautionary-tales-the-dunning-...
In terms of this strain, the actual rate of mutation is higher (5.6E-4 nucleotide changes/site/year vs 5.3E-4) [https://virological.org/t/preliminary-genomic-characterisati...]
The short answer is that 'The extent to which SARS-CoV-2 may evolve to escape immunity induced by infection or vaccination is not currently known'. However analysis has been carried out to work out how far from the receptor-binding site the mutations are, and how 'antibody-accessible' these are, with a few such as . No conclusions are drawn from this analysis.
Earlier on in the report (towards the end of page 1), this statement is given `One of these (the N501Y mutation) occurs in the region of the Spike protein, the receptor binding domain (RBD), that the virus uses to bind to the human ACE2 receptor. Changes in this region of the Spike protein can result in the virus changing its ACE2 binding specificity and alter antibody recognition`.
Saying all this, vaccines are designed to create a range of antibody responses, in order to stop this very fear of a single mutation rendering a whole vaccine useless. [https://www.nature.com/articles/d41586-020-02544-6] I also recall reading somewhere that adapting the vaccine to account for a mutation (much like is done yearly with the flue vaccine) is relatively easy, though I haven't managed to find that article again yet.
> Several aspects of this cluster are noteworthy for epidemiological and biological reasons and we report preliminary findings below. In summary: The B.1.1.7 lineage accounts for an increasing proportion of cases in parts of England. The number of B.1.1.7 cases, and the number of regions reporting B.1.1.7 infections, are growing. B.1.1.7 has an unusually large number of genetic changes, particularly in the spike protein. Three of these mutations have potential biological effects that have been described previously to varying extents:
> - Mutation N501Y is one of six key contact residues within the receptor-binding domain (RBD) and has been identified as increasing binding affinity to human and murine ACE2.
> - The spike deletion 69-70del has been described in the context of evasion to the human immune response but has also occurred a number of times in association with other RBD changes.
> - Mutation P681H is immediately adjacent to the furin cleavage site, a known location of biological significance.
> The rapid growth of this lineage indicates the need for enhanced genomic and epidemiological surveillance worldwide and laboratory investigations of antigenicity and infectivity.
https://www.cogconsortium.uk/wp-content/uploads/2020/12/Repo...
https://virological.org/t/preliminary-genomic-characterisati...